UGT1A1 and metabolic syndrome: So based on our findings, we can expect that when patients with the mutation of UGT1A1*6 and has a DBIL level greater than 4 μmol/L, they may have a certain natural resistance to dyslipidemia induced by antipsychotic drugs.